Humana Establishes Exclusive Coverage for iFuse in MIS SI Joint Fusion Procedures

SI-BONE announced that Humana revised its coverage policies to cover minimally invasive SI joint fusion using triangular titanium implants (the iFuse Implant System). Humana is one of the five largest commercial payers in the U.S., with over 12.7 million covered lives.

The revised policy provides coverage for minimally invasive sacroiliac joint fusion for chronic low back pain due to sacroiliac joint dysfunction, provided certain criteria are met.

“We are thrilled with Humana’s decision to cover MIS SI joint fusion procedures that use iFuse for its members, and with clinical criteria that aligns closely with guidelines from professional spine societies like NASS and ISASS,” said Jeffrey Dunn, President, Chief Executive Officer, and Chairman at SI-BONE. “Payors continue to rely on long-term outcomes from high-quality randomized controlled trials when establishing coverage criteria for new treatments which is a cornerstone of our culture. With this updated policy, Humana joins 36 other health plans that cover MIS SI joint fusion using the iFuse Implant System exclusively, as well as other large payors including United Healthcare, CIGNA and Aetna, which also provide positive coverage for iFuse procedures.”